Sonnet BioTherapeutics Ownership | Who Owns Sonnet BioTherapeutics?

Overview Forecast RevenueFinancials Chart

Sonnet BioTherapeutics Ownership Summary

Sonnet BioTherapeutics is owned by 0.05% institutional investors, and 99.95% retail investors. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.45% of its assets in Sonnet BioTherapeutics shares.

SONN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Sonnet BioTherapeutics	0.05%	-	99.95%
Sector	Healthcare Stocks	488.30%	11.08%	-399.38%
Industry	Biotech Stocks	307.10%	11.11%	-218.21%

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2022	1	-94.44%	2,000	-99.94%	-	0.00%	-	-100.00%	-	-100.00%
Jun 30, 2022	18	-14.29%	3,519,106	-41.21%	92	0.37%	6	-53.85%	6	100.00%
Mar 31, 2022	21	31.25%	5,985,793	50.03%	157	1.43%	13	62.50%	3	200.00%
Dec 31, 2021	16	23.08%	3,989,736	42.96%	105	1.95%	8	33.33%	1	-
Sep 30, 2021	13	30.00%	2,790,790	164.02%	73	9.49%	6	50.00%	1	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Institutional Extnd Mkt Idx Tr	28.10K	0.45%	26.26K
Fidelity Extended Market Index	19.79K	0.29%	-139.00
Cinvest Azero Global FI	7.10K	0.10%	2.42K
Fidelity Total Market Index	6.32K	0.09%	4.90K
Fidelity Series Total Market Index	3.34K	0.05%	-
Spartan Total Market Index Pool G	1.89K	0.03%	1.69K
Northern Trust Extended Eq Market Idx	92.00	0.00%	-
NT Ext Equity Mkt Idx Fd - L	92.00	0.00%	-
Spartan Extended Market Index Pool F	139.00	0.00%	139.00
Spartan Extended Market Index Pool E	57.00	0.00%	-

Insider Transactions Trends

Date	Buy	Sell
2023 Q4	4	-
2023 Q3	-	-
2023 Q2	4	-
2023 Q1	1	-
2022 Q4	-	-

SONN Ownership FAQ

Who Owns Sonnet BioTherapeutics?

Sonnet BioTherapeutics shareholders are primarily institutional investors at 0.05%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Sonnet BioTherapeutics's industry, Biotech Stocks , is 307.10%, which Sonnet BioTherapeutics falls below.

Does Blackrock own Sonnet BioTherapeutics?

BlackRock is not among the top 10 institutional shareholders of Sonnet BioTherapeutics.

Who is the top mutual fund holder of Sonnet BioTherapeutics shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Sonnet BioTherapeutics shares, with 0.45% of its total shares outstanding invested in 28.1K Sonnet BioTherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools